FIM
GSK icon

Freedom Investment Management’s GSK GSK Stock Holding History

Freedom Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,496
Closed -$403K – 362
2025
Q2 		$403K Sell
10,496
-1,164
-10% -$44.5K 0.03% 510
2025
Q1 		$452K Sell
11,660
-57
-0.5% -$2.09K 0.04% 453
2024
Q4 		$396K Buy
11,717
+999
+9% +$36K 0.03% 495
2024
Q3 		$438K Sell
10,718
-1,045
-9% -$42.8K 0.03% 474
2024
Q2 		$453K Sell
11,763
-1,467
-11% -$61.7K 0.04% 456
2024
Q1 		$567K Sell
13,230
-1,372
-9% -$56.6K 0.05% 406
2023
Q4 		$541K Sell
14,602
-20,781
-59% -$746K 0.04% 412
2023
Q3 		$1.28M Sell
35,383
-5,886
-14% -$209K 0.16% 152
2023
Q2 		$1.47M Sell
41,269
-5,747
-12% -$206K 0.17% 147
2023
Q1 		$1.67M Sell
47,016
-8,599
-15% -$301K 0.19% 139
2022
Q4 		$1.95M Sell
55,615
-5,430
-9% -$181K 0.22% 114
2022
Q3 		$1.8M Buy
61,045
+6,283
+11% +$238K 0.21% 115
2022
Q2 		$2.98M Buy
54,762
+25,336
+86% +$1.4M 0.32% 72
2022
Q1 		$1.6M Buy
+29,426
New +$1.6M 0.14% 185
2021
Q3 		– Sell
-5,046
Closed -$251K – 858
2021
Q2 		$251K Sell
5,046
-200
-4% -$9.61K 0.02% 755
2021
Q1 		$234K Sell
5,246
-13,031
-71% -$591K 0.02% 737
2020
Q4 		$841K Buy
18,277
+2
+0% +$92 0.09% 212
2020
Q3 		$860K Sell
18,275
-2,047
-10% -$103K 0.09% 189
2020
Q2 		$1.04M Buy
20,322
+3,172
+18% +$163K 0.11% 161
2020
Q1 		$942K Sell
17,150
-940
-5% -$50.1K 0.08% 203
2019
Q4 		$1.06M Sell
18,090
-2,036
-10% -$113K 0.09% 198
2019
Q3 		$1.07M Sell
20,126
-1,142
-5% -$58.7K 0.09% 199
2019
Q2 		$1.06M Sell
21,268
-1,612
-7% -$80.9K 0.09% 211
2019
Q1 		$1.2M Sell
22,880
-6,908
-23% -$345K 0.1% 206
2018
Q4 		$1.42M Sell
29,788
-3,614
-11% -$178K 0.11% 190
2018
Q3 		$1.68M Sell
33,402
-528
-2% -$26.8K 0.11% 193
2018
Q2 		$1.71M Buy
33,930
+6,601
+24% +$332K 0.1% 200
2018
Q1 		$1.33M Buy
27,329
+4,313
+19% +$201K 0.07% 286
2017
Q4 		$1.02M Buy
23,016
+640
+3% +$29.6K 0.05% 356
2017
Q3 		$1.14M Sell
22,376
-597
-3% -$30.3K 0.06% 292
2017
Q2 		$1.24M Buy
22,973
+3,569
+18% +$190K 0.07% 240
2017
Q1 		$1.02M Buy
19,404
+4,163
+27% +$211K 0.06% 285
2016
Q4 		$734K Sell
15,241
-57
-0.4% -$2.82K 0.05% 357
2016
Q3 		$825K Buy
15,298
+5,404
+55% +$296K 0.05% 294
2016
Q2 		$536K Sell
9,894
-2,103
-18% -$111K 0.04% 398
2016
Q1 		$608K Buy
11,997
+974
+9% +$48.5K 0.04% 336
2015
Q4 		$556K Sell
11,023
-8,715
-44% -$444K 0.04% 372
2015
Q3 		$338K Buy
19,738
+11,624
+143% +$605K 0.03% 435
2015
Q2 		$422K Buy
8,114
+2,073
+34% +$117K 0.04% 395
2015
Q1 		$348K Buy
+6,041
New +$346K 0.04% 430
2014
Q1 		– Sell
-3,070
Closed -$205K – 451
2013
Q4 		$205K Buy
+3,070
New +$199K 0.05% 385

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Freedom Investment Management's GSK Position: Q3 2025 in Review

Freedom Investment Management sold out of GSK (GSK) in Q3 2025, closing a stake of 10,496 shares — an estimated $403K sold.

Freedom Investment Management first reported a position in GSK in Q4 2013 and held it in 41 quarters. The position peaked at $2.98M in Q2 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Freedom Investment Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 10,496 GSK shares in Q3 2025, an estimated $403K.
  • Freedom Investment Management first reported a position in GSK in Q4 2013 and held it in 41 quarters.
  • Freedom Investment Management's GSK position peaked at $2.98M in Q2 2022.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.